Literature DB >> 20067557

Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemia.

Paul A Bartley1, Michael H Martin-Harris, Bradley J Budgen, David M Ross, Alexander A Morley.   

Abstract

Isolation and sequencing of the translocation breakpoint in chronic myeloid leukaemia-(CML) and acute promyelocytic leukaemia (APML) may help to elucidate the mechanism of translocation and provide a molecular marker for monitoring of minimal residual disease. Amplification across the translocation breakpoint was performed in samples from 91 patients with CML and 15 patients with APML using single-tube multiplex polymerase chain reaction (PCR) involving 308 primers for CML and 40 primers for APML. Nonspecific amplification was removed by a modification of PCR, termed sequential hybrid primer PCR (SHP-PCR), which involved two sequential rounds of PCR, each of which used a low concentration of a specially designed hybrid primer. The resultant amplified material was sequenced. The method as finally developed was simple quick and robust. The translocation breakpoint was successfully isolated and sequenced in all 106 samples. The strategy of highly multiplexed PCR followed by SHP-PCR is thus an effective method for isolating the translocation breakpoint in CML and APML. It may also be applicable to other haematological disorders characterised by translocation, deletion or inversion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20067557     DOI: 10.1111/j.1365-2141.2009.08071.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

Review 1.  Molecular monitoring.

Authors:  Simona Soverini; Gianantonio Rosti; Michele Baccarani; Giovanni Martinelli
Journal:  Curr Hematol Malig Rep       Date:  2014-03       Impact factor: 3.952

Review 2.  Molecular monitoring of chronic myeloid leukemia: present and future.

Authors:  Cecilia Ching Sze Yeung; Daniel Egan; Jerald P Radich
Journal:  Expert Rev Mol Diagn       Date:  2016-09-06       Impact factor: 5.225

Review 3.  Chronic myelogenous leukemia: monitoring response to therapy.

Authors:  Susan Branford; Jodi Prime
Journal:  Curr Hematol Malig Rep       Date:  2011-06       Impact factor: 3.952

4.  Detection of DNA fusion junctions for BCR-ABL translocations by Anchored ChromPET.

Authors:  Yoshiyuki Shibata; Ankit Malhotra; Anindya Dutta
Journal:  Genome Med       Date:  2010-09-22       Impact factor: 11.117

Review 5.  Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances.

Authors:  Cosimo Cumbo; Luisa Anelli; Giorgina Specchia; Francesco Albano
Journal:  Cancer Manag Res       Date:  2020-05-06       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.